CKD
Conditions
Keywords
CKD, Diabetes, Ameircan Indians, COVID-19,
Brief summary
Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) OR COVID-19 related Addition: The aim of this addition activity is to track the impact of the COVID-19 epidemic on participants with diabetes and chronic kidney disease (CKD). Investigators have modified the original HBKC Study protocol to expand data currently collected from study participants to include data in the following domains linked to the COVID-19 epidemic: symptoms of COVID-19 disease, access to healthcare, and impact on health related behaviors (such as medication adherence, physical activity, dietary behaviors, smoking, and alcohol use).
Detailed description
Investigators will administer a survey by phone or mail to all participants screened for diabetes and chronic kidney disease in the original HBKC study protocol. The survey will address to the following aims: Aim 1. Develop a phone-based and or mail based survey to understand the impact of COVID19 on patient-reported outcomes for adults with diabetes and CKD. Aim 2. Test the feasibility and acceptability of this phone-based and or mail based survey in the HBKC cohort.
Interventions
None listed
Sponsors
University of New Mexico
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
21 Years to 80 Years
Inclusion criteria
* Willingness to participate in the phone-based and or mail based survey.
Exclusion criteria
* None
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of Participants With Problems in Their Health Care Due to COVID-19 Related Isolation | six months | Document COVID-19 disruptions in normal health care check-ups, transportation, economic status, and access to food and water. |
Countries
United States
Participant flow
Recruitment details
We recruited 309 participants from 540 individuals who were initially approached by phone and/or mailings from September 2020 to July 2021 to participate in the survey.
Participants by arm
| Arm | Count |
|---|---|
| Single Group Survey Survey of the entire group | 309 |
| Total | 309 |
Baseline characteristics
| Characteristic | Single Group Survey |
|---|---|
| Age, Continuous | 57.6 years STANDARD_DEVIATION 14.8 |
| Race (NIH/OMB) American Indian or Alaska Native | 309 Participants |
| Race (NIH/OMB) Asian | 0 Participants |
| Race (NIH/OMB) Black or African American | 0 Participants |
| Race (NIH/OMB) More than one race | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants |
| Race (NIH/OMB) White | 0 Participants |
| Sex: Female, Male Female | 197 Participants |
| Sex: Female, Male Male | 112 Participants |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | 0 / 309 |
| other Total, other adverse events | 0 / 309 |
| serious Total, serious adverse events | 0 / 309 |
Outcome results
Primary
Number of Participants With Problems in Their Health Care Due to COVID-19 Related Isolation
Document COVID-19 disruptions in normal health care check-ups, transportation, economic status, and access to food and water.
Time frame: six months
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| COVID Survey | Number of Participants With Problems in Their Health Care Due to COVID-19 Related Isolation | 155 Participants |